BrainVisio

BrainVisio is an intelligent multimodal MRI analysis platform designed for brain health management and neurological disease risk assessment.

Brain Age Assessment — Gaining Insight into the Brain Beyond Time

Brain Visio leverages widely available 3D T1-weighted structural MRI to predict the brain’s biological age using advanced AI models.
By comparing the predicted brain age with the individual’s chronological age, the system provides an accurate assessment of brain health and potential aging degree. Beyond delivering quantitative results, it integrates large language models to generate personalized health insights and lifestyle recommendations, empowering users to maintain brain health and slow neurodegenerative processes in their daily lives.

Brain Region Analysis and Neurodegenerative Insights — From Precise Segmentation to AI-Driven Risk Assessment

The system integrates a high-precision brain region segmentation algorithm that automatically identifies over a hundred brain structures and computes each region’s volume percentile within the standard population, revealing individual structural differences. Building on these quantitative results, Brain Visio further enables AI-driven risk assessment, stage evaluation, and progression prediction for neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD).

Cerebral Small Vessel Disease Analysis — Brain Health Assessment from a Microscopic Perspective

The system automatically generates comprehensive reports on white matter integrity, providing clinicians with a full-spectrum brain health map that spans from macroscopic structures to microscopic connectivity.